- Home
- ALT vs SMC Comparison
ALT vs SMC Comparison
Compare ALT & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- SMC
- Stock Information
- Founded
- ALT 1997
- SMC 2009
- Country
- ALT United States
- SMC United States
- Employees
- ALT N/A
- SMC N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- SMC
- Sector
- ALT Health Care
- SMC
- Exchange
- ALT Nasdaq
- SMC NYSE
- Market Cap
- ALT 397.4M
- SMC 322.4M
- IPO Year
- ALT N/A
- SMC 2012
- Fundamental
- Price
- ALT $4.19
- SMC $24.42
- Analyst Decision
- ALT Strong Buy
- SMC
- Analyst Count
- ALT 6
- SMC 0
- Target Price
- ALT $18.20
- SMC N/A
- AVG Volume (30 Days)
- ALT 11.7M
- SMC 164.7K
- Earning Date
- ALT 08-07-2025
- SMC 08-07-2025
- Dividend Yield
- ALT N/A
- SMC N/A
- EPS Growth
- ALT N/A
- SMC N/A
- EPS
- ALT N/A
- SMC N/A
- Revenue
- ALT $20,000.00
- SMC $444,383,000.00
- Revenue This Year
- ALT N/A
- SMC N/A
- Revenue Next Year
- ALT $1,557,547.90
- SMC N/A
- P/E Ratio
- ALT N/A
- SMC N/A
- Revenue Growth
- ALT N/A
- SMC N/A
- 52 Week Low
- ALT $2.90
- SMC $23.53
- 52 Week High
- ALT $11.16
- SMC $45.89
- Technical
- Relative Strength Index (RSI)
- ALT 39.67
- SMC 42.59
- Support Level
- ALT $4.33
- SMC $23.96
- Resistance Level
- ALT $4.79
- SMC $25.29
- Average True Range (ATR)
- ALT 0.52
- SMC 0.97
- MACD
- ALT -0.16
- SMC 0.01
- Stochastic Oscillator
- ALT 26.92
- SMC 34.23
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.